| Date | Time | Source | Headline | Symbol | Company |
| 10/04/2007 | 6:38PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/04/2007 | 6:38PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/04/2007 | 6:35PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/04/2007 | 6:35PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/02/2007 | 2:53PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/02/2007 | 2:53PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/02/2007 | 2:50PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/02/2007 | 2:50PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/02/2007 | 2:47PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/02/2007 | 2:47PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/02/2007 | 2:43PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/02/2007 | 2:43PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/02/2007 | 2:40PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/02/2007 | 2:40PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/02/2007 | 2:37PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/02/2007 | 2:37PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/01/2007 | 12:02PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc (Other) (8-K) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 10/01/2007 | 7:00AM | PR Newswire (US) | FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/28/2007 | 5:52PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc (Other) (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/27/2007 | 5:13PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc (Other) (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/21/2007 | 9:00AM | PR Newswire (US) | One Year Study of Exenatide Treatment Showed Improved Beta-Cell Function | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/19/2007 | 1:22PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc (Other) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/19/2007 | 1:21PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc (Other) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/18/2007 | 4:48PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/18/2007 | 4:47PM | Edgar (US Regulatory) | Amylin Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4) | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/14/2007 | 4:37PM | PR Newswire (US) | Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Dia | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 09/10/2007 | 11:17AM | PR Newswire (US) | Seven Summits Research Releases Comments on XOM, IBM, SNDK, AMLN, and IFX | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/31/2007 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals to Present at BioCentury NewsMakers Conference, Thomas Weisel Healthcare Conference and Bear Stearns Heal | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 08/07/2007 | 5:54PM | PR Newswire (US) | Amylin Resale Registration Statement Declared Effective by SEC | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |
| 07/23/2007 | 4:05PM | PR Newswire (US) | Amylin Pharmaceuticals Reports Second Quarter Financial Results | NASDAQ:AMLN | Amylin Pharmaceuticals, Inc. (MM) |